Theratechnologies (TSE:TH) Stock Passes Above 50-Day Moving Average - Time to Sell?

Key Points

• Theratechnologies shares have crossed above their fifty-day moving average, trading as high as C$4.37, indicating potential upward momentum.
• Analysts from Jones Trading have downgraded Theratechnologies from a "strong-buy" to a "hold" rating, suggesting caution for investors.
• The company is classified as a specialty pharmaceutical firm focusing on treatments for HIV, operating primarily in Canada and the U.S.

Theratechnologies Inc. (TSE:TH - Get Free Report) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$3.81 and traded as high as C$4.37. Theratechnologies shares last traded at C$4.36, with a volume of 38,205 shares traded.

Analysts Set New Price Targets

Separately, Jones Trading downgraded Theratechnologies from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 3rd.

Theratechnologies Stock Performance

The firm has a market capitalization of C$139.11 million, a P/E ratio of -49.35, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of -293.92, a quick ratio of 0.64 and a current ratio of 1.08. The stock has a 50-day moving average of C$3.84 and a 200 day moving average of C$3.15.

About Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.